A vaccine is not too far for COVID-19
Author(s) -
Shailesh Kumar Patel,
Mamta Pathak,
Ruchi Tiwari,
Mohd. Iqbal Yatoo,
Yashpal Singh Malik,
Ranjit Sah,
Ali A. Rabaan,
Khan Sharun,
Kuldeep Dhama,
D. Katterine BonillaAldana,
Alfonso J. RodríguezMorales
Publication year - 2020
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.12744
Subject(s) - covid-19 , virology , medicine , outbreak , infectious disease (medical specialty) , disease
Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-19) (January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been a significant hope for the development of vaccines against this emerging coronavirus. Dozens of vaccine candidates are currently under assessment in clinical trials already recruiting patients, then there is a real chance to have effective biologicals in relatively short-time, compared to other vaccines.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom